How stimulant drugs affect dopamine receptor signaling in the brain

Stimulant-induced excitatory and inhibitory dopamine receptor signaling and trafficking

NIH-funded research Massachusetts General Hospital · NIH-10930936

This study is looking at how stimulant medications, like those used for ADHD, affect brain receptors over time, especially after they've been used repeatedly, to better understand addiction and improve treatment options.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-10930936 on NIH RePORTER

What this research studies

This research investigates the effects of stimulant drugs, such as amphetamines and methylphenidate, on dopamine receptors in the brain. It aims to understand how these drugs cause changes in receptor signaling and trafficking over time, particularly after repeated use. By using advanced imaging techniques like PET and fMRI in non-human primates, the study will track the internalization and recovery of dopamine receptors following stimulant exposure. This knowledge could help clarify the mechanisms behind addiction and inform treatment strategies.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with a history of stimulant drug use or those at risk for substance use disorders.

Not a fit: Patients who do not use stimulants or have no history of substance use disorders may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment of substance use disorders.

How similar studies have performed: Previous research has shown promising results in understanding dopamine receptor dynamics, but this specific approach using simultaneous PET and fMRI is relatively novel.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.